Early Changes in CT Perfusion Parameters: Primary Renal Carcinoma Versus Metastases After Treatment with Targeted Therapy.

Fan, Alice C; Sundaram, Vandana; Kino, Aya; Schmiedeskamp, Heiko; Metzner, Thomas J; Kamaya, Aya

Fan, Alice C; Sundaram, Vandana; Kino, Aya; Schmiedeskamp, Heiko; Metzner, Thomas J; Kamaya, Aya.

Afiliação

Fan AC; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sundaram V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Kino A; Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.
Schmiedeskamp H; Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Metzner TJ; Siemens Medical Solutions USA, Inc., Malvern, PA 19355, USA.
Kamaya A; Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Cancers (Basel) ; 11(5)2019 04 30.

Article em En | MEDLINE | ID: mdl-31052289

Palavras-chave

CT perfusion; biomarker; metastases; renal cell carcinoma; targeted therapy; therapeutic response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google